{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:50:41Z","timestamp":1771339841857,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Cardiovascular Interventions"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:sec>\n            <jats:title>Background\u2014<\/jats:title>\n            <jats:p>Significant prosthetic paravalvular leakage (PVL) could have serious clinical consequences and impairs survival. Reoperation is associated with a high mortality rate, and transcatheter closure is a new treatment modality for high-risk patients. The goal of this study was to determine safety and midterm clinical efficacy of transcatheter PVL closure using an open transapical approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and Results\u2014<\/jats:title>\n            <jats:p>\n              All consecutive patients who underwent transcatheter PVL closure in our center were prospectively enrolled. Pre- and postprocedural quality of life and 6-minute walk test were ascertained. All outcomes were defined according to the Valve Academic Research Consortium-2 consensus document. In total, 37 consecutive patients (mean age 67\u00b112 years, 65% male, logistic European System for Cardiac Operative Risk Evaluation 27\u00b117%, Society of Thoracic Surgeons score 7\u00b14%) with severe symptomatic PVL in mitral (81%) or aortic (19%) position underwent transcatheter PVL closure. Procedure success was 86%. Early safety at 30 days (ie, event-free survival) was 84%. The 1-year survival rate was 66%. New York Heart Association functional class and quality of life significantly improved. Clinical efficacy (ie, survival free of stroke, rehospitalization, New York Heart Association 3\/4, and device-related dysfunction) was 49% at 3 months and 31% at 1 year. Moderate to severe residual PVL was associated with all-cause mortality (hazard ratio, 3.9; 95% confidence interval, 1.2\u201312.1;\n              <jats:italic>P<\/jats:italic>\n              =0.03).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions\u2014<\/jats:title>\n            <jats:p>The open transapical approach to PVL closure in high-risk patients has a high procedural success rate with an acceptable risk of adverse outcomes. This is the first study to prove an increased functional capacity and quality of life after transapical PVL closure. Residual PVL is associated with 1-year mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circinterventions.113.001171","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T02:59:28Z","timestamp":1407293968000},"page":"611-620","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Open Transapical Approach to Transcatheter Paravalvular Leakage Closure"],"prefix":"10.1161","volume":"7","author":[{"given":"Vincent J.","family":"Nijenhuis","sequence":"first","affiliation":[{"name":"From the Department of Cardiology (V.J.N., M.J.S., M.C.P., J.M.t.B.) and Department of Cardiothoracic Surgery (R.H.H., T.L.d.K.), St. Antonius Hospital, Nieuwegein, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Swaans","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology (V.J.N., M.J.S., M.C.P., J.M.t.B.) and Department of Cardiothoracic Surgery (R.H.H., T.L.d.K.), St. Antonius Hospital, Nieuwegein, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn C.","family":"Post","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology (V.J.N., M.J.S., M.C.P., J.M.t.B.) and Department of Cardiothoracic Surgery (R.H.H., T.L.d.K.), St. Antonius Hospital, Nieuwegein, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin H.","family":"Heijmen","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology (V.J.N., M.J.S., M.C.P., J.M.t.B.) and Department of Cardiothoracic Surgery (R.H.H., T.L.d.K.), St. Antonius Hospital, Nieuwegein, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"de Kroon","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology (V.J.N., M.J.S., M.C.P., J.M.t.B.) and Department of Cardiothoracic Surgery (R.H.H., T.L.d.K.), St. Antonius Hospital, Nieuwegein, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurrien M.","family":"ten Berg","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology (V.J.N., M.J.S., M.C.P., J.M.t.B.) and Department of Cardiothoracic Surgery (R.H.H., T.L.d.K.), St. Antonius Hospital, Nieuwegein, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608083350607"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041451"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200384"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/1010-7940(91)90105-S"},{"key":"e_1_3_2_6_2","first-page":"56","article-title":"Risk of reoperation for mitral bioprosthesis dysfunction.","volume":"21","author":"Jaussaud N","year":"2012","unstructured":"Jaussaud N, Gariboldi V, Grisoli D, Berbis J, Kerbaul F, Riberi A, Collart F. Risk of reoperation for mitral bioprosthesis dysfunction. J Heart Valve Dis. 2012;21:56\u201360.","journal-title":"J Heart Valve Dis"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(99)00363-2"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2011.07.003"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.07.041"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.03.074"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.001"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.23264"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.110.009449"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc5713"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510140062030"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21939"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.110.960955"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.25006"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21542"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2008.10.005"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2010.06.004"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.04.013"},{"key":"e_1_3_2_23_2","first-page":"E107","article-title":"A novel method for closing the percutaneous transapical access tract using coils and gelatin matrix.","volume":"22","author":"Martinez CA","year":"2010","unstructured":"Martinez CA, Rosen R, Cohen H, Ruiz CE. A novel method for closing the percutaneous transapical access tract using coils and gelatin matrix. J Invasive Cardiol. 2010;22:E107\u2013E109.","journal-title":"J Invasive Cardiol"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr439"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivs210"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs608"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2011.12.035"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2012.01.023"},{"key":"e_1_3_2_29_2","first-page":"497","article-title":"Transapical closure of mitral paravalvular leaks with use of Amplatzer vascular plug III.","volume":"25","author":"Smolka G","year":"2013","unstructured":"Smolka G, Pysz P, Jasinski M, Goco\u0142 R, Domaradzki W, Hudziak D, Deja M, Ocha\u0142a A, Gasior Z. Transapical closure of mitral paravalvular leaks with use of Amplatzer vascular plug III. J Invasive Cardiol. 2013;25:497\u2013501.","journal-title":"J Invasive Cardiol"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2011.05.018"},{"key":"e_1_3_2_31_2","first-page":"208","article-title":"Percutaneous closure of mitral paravalvular leaks: a systematic review and meta-analysis.","volume":"21","author":"Mookadam F","year":"2012","unstructured":"Mookadam F, Raslan SF, Jiamsripong P, Jalal U, Murad MH. Percutaneous closure of mitral paravalvular leaks: a systematic review and meta-analysis. J Heart Valve Dis. 2012;21:208\u2013217.","journal-title":"J Heart Valve Dis"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2014.01.159"},{"key":"e_1_3_2_33_2","first-page":"792","article-title":"Early and late results of the surgical correction of cardiac prosthetic paravalvular leaks.","volume":"14","author":"Akins CW","year":"2005","unstructured":"Akins CW, Bitondo JM, Hilgenberg AD, Vlahakes GJ, Madsen JC, MacGillivray TE. Early and late results of the surgical correction of cardiac prosthetic paravalvular leaks. J Heart Valve Dis. 2005;14:792\u2013729, discussion 799\u2013800.","journal-title":"J Heart Valve Dis"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(99)00358-9"},{"key":"e_1_3_2_35_2","first-page":"426","article-title":"Does the morphology of mitral paravalvular leaks influence symptoms and hemolysis?","volume":"10","author":"Genoni M","year":"2001","unstructured":"Genoni M, Franzen D, Tavakoli R, Seiffert B, Graves K, Jenni R, Turina M. Does the morphology of mitral paravalvular leaks influence symptoms and hemolysis? J Heart Valve Dis. 2001;10:426\u2013430.","journal-title":"J Heart Valve Dis"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209655"}],"container-title":["Circulation: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCINTERVENTIONS.113.001171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T02:53:38Z","timestamp":1715568818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCINTERVENTIONS.113.001171"}},"subtitle":["A Preliminary Experience"],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1161\/CIRCINTERVENTIONS.113.001171"],"URL":"https:\/\/doi.org\/10.1161\/circinterventions.113.001171","relation":{},"ISSN":["1941-7640","1941-7632"],"issn-type":[{"value":"1941-7640","type":"print"},{"value":"1941-7632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"2013-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-07-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}